FDA Adverse Event Malfunction Summary report: N

I-STAT EC4+CARTRIDGE

MDR report key: 6938668 · Received October 10, 2017

Report

Report Number
2245578-2017-00535
Event Type
Malfunction
Date Received
October 10, 2017
Date of Event
March 11, 2017
Report Date
October 10, 2017
Manufacturer
ABBOTT POINT OF CARE
Product Code
JGS
UDI-DI
10054749000095
PMA / PMN Number
K912387
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). APOC LABELING WAS EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT. THE INVESTIGATION WAS COMPLETED ON 04/05/2016. RETAIN PRODUCT WAS TESTED AND FUNCTIONING ACCORDING TO SPECIFICATION. INVESTIGATION: THE DEVICE HISTORY RECORD (DHR) FOR THIS LOT WAS REVIEWED. THE LOT PASSED FINISHED GOODS (FG) RELEASE CRITERIA. FORTY RETAINED CARTRIDGES FROM THE LOT WERE TESTED USING A WHOLE BLOOD (WB) AND A LOW HCT BLOOD SAMPLE. THE COMPLIANT WAS NOT REPRODUCED. TESTING MET THE ACCEPTANCE CRITERIA FOUND IN Q04.01.003 REV. X, APPENDIX 1 - PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. THREE HUNDRED RETURNED CARTRIDGES FROM THE LOT WERE TESTED USING WB AND LOW HCT BLOOD SAMPLES AND I-STAT LEVEL 1 CONTROL (L1). THE COMPLAINT WAS NOT REPRODUCED. TESTING MET THE ACCEPTANCE CRITERIA FOUND IN Q04.01.003 REV. X, APPENDIX 1 - PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. NO DEFICIENCY HAS BEEN IDENTIFIED. ASSESSMENT: THE COMPLAINT INVESTIGATION CONCLUDED THERE WAS NO PRODUCT DEFICIENCY AND THAT THE I-STAT CARTRIDGE LOT IS MEETING SPECIFICATION. THE SAMPLES WERE CONTRIVED FOR USE IN AN INTERNAL APOC VERIFICATION STUDY. PATIENT RESULTS INSIDE THE LER ZONE POSE A RISK TO PATIENT SAFETY. WHEN VALUES FALL INSIDE THE LER ZONES, POTENTIAL HARM CAN OCCUR TO THE PATIENTS IF THESE RESULTS ARE UTILIZED IN MEDICAL DECISION-MAKING. THE LER ESTABLISHED FOR THE I-STAT SODIUM ASSAY IS 18 MM UP TO 146 MM AND 14 MM AFTER THAT.

Description of Event or Problem · 1

ON (B)(6) 2015, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT EC4+ CARTRIDGES THAT YIELDED SUSPECTED DISCREPANT HCT RESULTS. THE ISSUE OCCURED INTERNALLY DURING VERIFICATION. THERE WAS NO PATIENT TESTING PERFORMED. (B)(6). AT THE TIME OF THE EVENT THERE WAS NO INDICATION OF A PRODUCT MALFUNCTION BASED ON THE INFORMATION PROVIDED AND ASSESSED BY APOC, HOWEVER THIS MDR IS A RETROSPECTIVE FILING IN RESPONSE TO AN OBSERVATION FROM AN FDA INSPECTION CONDUCTED MAY 8TH TO 12TH, 2017 AT ABBOTT POINT OF CARE ((B)(6)).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
717271 I-STAT EC4+CARTRIDGE EC4+ CARTRIDGE JGS ABBOTT POINT OF CARE NA K15273 10054749000095

Patients

Seq Age Sex Outcome Treatment
1